Back to Search
Start Over
Multidisciplinar treatment in postpartum depression. Coordinated attention of psychiatrist and midwife: use of desvenlafaxine while breastfeeding
- Source :
- European Psychiatry, Vol 65, Pp S562-S562 (2022)
- Publication Year :
- 2022
- Publisher :
- Cambridge University Press, 2022.
-
Abstract
- Introduction Postpartum depression is a common psychiatric complication after pregnancy, so it is necessary to know the depressive symptoms to be able to carry out early prevention and treatment interventions. It is a health problem with a prevalence that ranges between 10–15% according to the world literature. Behavioral and psychosocial factors favoring postpartum depression are recognized. Objectives -To emphasize multidisciplinary treatment in the combined attention to the mother-baby. -To demostrate decreased risk for baby if early use of antidepressants. -To evaluate of the impact of desvenlafaxine during breastfeeding. Methods Descriptive-study. Clinical Case. Evolution of postpartum depression. Follow-up of a patient based on coordination with the midwife attending a successful breastfeeding while treatment with desvenlafaxine. Use of Edinburgh Postnatal Depression Scale. Results -Use of Desvenlafaxine 50-100mg being compatible with breastfeeding, in adittion to depressive illness improvement *Obstetrics and psychiatry guidelines and safety considerations for lactation and antidepressants). Conclusions -Postpartum-depression could be the first episode of depression in a healthy woman. Sometimes there are unnoticed symptoms during pregnancy. -Health-care for puerperal women should be focused on both, biomedical and psychosocial issues, with a coordinated multidisciplinar team. -Due to important early treatment during the puerperium, it is recommended a close medical control of the mother´s psychological state after the birth. -If depression appears, a psychiatric follow-up is kept even after the episode remission. Besides, the role of the midwife is essential during lactation. -Some antidepressants like desvenlafaxine have demonstrated benefits over the risk of the baby´s complications without treatment. Disclosure No significant relationships.
Details
- Language :
- English
- ISSN :
- 09249338 and 17783585
- Volume :
- 65
- Database :
- Directory of Open Access Journals
- Journal :
- European Psychiatry
- Publication Type :
- Academic Journal
- Accession number :
- edsdoj.4487ec10d874b93bab509278c5ca7b6
- Document Type :
- article
- Full Text :
- https://doi.org/10.1192/j.eurpsy.2022.1439